JP2016536312A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536312A5 JP2016536312A5 JP2016527304A JP2016527304A JP2016536312A5 JP 2016536312 A5 JP2016536312 A5 JP 2016536312A5 JP 2016527304 A JP2016527304 A JP 2016527304A JP 2016527304 A JP2016527304 A JP 2016527304A JP 2016536312 A5 JP2016536312 A5 JP 2016536312A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nanoparticle
- cell
- nanoparticle composition
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020028423A JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899080P | 2013-11-01 | 2013-11-01 | |
| US61/899,080 | 2013-11-01 | ||
| US201462040242P | 2014-08-21 | 2014-08-21 | |
| US62/040,242 | 2014-08-21 | ||
| PCT/US2014/063545 WO2015066535A1 (en) | 2013-11-01 | 2014-10-31 | Modular particles for immunotherapy |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020028423A Division JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028424A Division JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016536312A JP2016536312A (ja) | 2016-11-24 |
| JP2016536312A5 true JP2016536312A5 (https=) | 2017-10-19 |
| JP6845691B2 JP6845691B2 (ja) | 2021-03-24 |
Family
ID=51999513
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016527304A Active JP6845691B2 (ja) | 2013-11-01 | 2014-10-31 | 免疫療法のための調節粒子 |
| JP2020028424A Withdrawn JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Active JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2022043714A Withdrawn JP2022078345A (ja) | 2013-11-01 | 2022-03-18 | 免疫療法のための調節粒子 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020028424A Withdrawn JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Active JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2022043714A Withdrawn JP2022078345A (ja) | 2013-11-01 | 2022-03-18 | 免疫療法のための調節粒子 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9884026B2 (https=) |
| EP (1) | EP3062779B1 (https=) |
| JP (4) | JP6845691B2 (https=) |
| KR (2) | KR102460800B1 (https=) |
| CN (2) | CN105848649B (https=) |
| AU (4) | AU2014342004B2 (https=) |
| CA (2) | CA2929277C (https=) |
| ES (1) | ES2982087T3 (https=) |
| RU (1) | RU2672055C2 (https=) |
| WO (1) | WO2015066535A1 (https=) |
| ZA (1) | ZA201602826B (https=) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2347775T (pt) | 2005-12-13 | 2020-07-14 | The President And Fellows Of Harvard College | Estruturas em andaime para transplante celular |
| JP6104806B2 (ja) | 2010-10-06 | 2017-03-29 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル |
| US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
| US9603800B2 (en) | 2012-04-12 | 2017-03-28 | Yale University | Methods of treating inflammatory and autoimmune diseases and disorders using nanolipogels |
| CN104244929B (zh) | 2012-04-16 | 2017-04-05 | 哈佛学院董事会 | 用于调节免疫反应的介孔二氧化硅组合物 |
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| CN105188741A (zh) | 2013-04-03 | 2015-12-23 | 阿勒丁医疗公司 | 新型纳米颗粒组合物 |
| KR102460800B1 (ko) | 2013-11-01 | 2022-10-31 | 예일 유니버시티 | 면역요법용 모듈러 입자 |
| WO2015108912A1 (en) | 2014-01-16 | 2015-07-23 | MUSC Foundation for Research and Development | Targeted nanocarriers for the administration of immunosuppressive agents |
| WO2015148971A2 (en) | 2014-03-27 | 2015-10-01 | Research Foundation Of The City University Of New York | Method for detecting or treating triple negative breast cancer |
| JP7348708B2 (ja) | 2014-04-30 | 2023-09-21 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 組み合わせワクチン装置および癌細胞を殺滅する方法 |
| HK1247861A1 (zh) | 2015-01-30 | 2018-10-05 | President And Fellows Of Harvard College | 用於癌症治疗的肿瘤周围和肿瘤内部材料 |
| EP3270932B1 (en) | 2015-03-16 | 2024-08-21 | PDX Pharmaceuticals, Inc. | Cross-linked polymer modified nanoparticles |
| WO2016164705A1 (en) | 2015-04-10 | 2016-10-13 | Omar Abdel-Rahman Ali | Immune cell trapping devices and methods for making and using the same |
| US10493030B2 (en) | 2015-05-22 | 2019-12-03 | Aphios Corporation | Combination HIV therapeutic |
| IL293655B2 (en) * | 2015-05-27 | 2025-04-01 | Univ Northwestern | Modified carbohydrate particles and particulate compositions for modulating immune response |
| CN120392779A (zh) | 2015-06-15 | 2025-08-01 | 华盛顿大学 | 用于延长血液和淋巴组织中的药物水平的多药脂质纳米颗粒组合物和相关方法 |
| JP6882782B2 (ja) | 2015-08-04 | 2021-06-02 | デューク ユニバーシティ | 遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法 |
| US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
| EP3411475B1 (en) | 2016-02-06 | 2025-08-27 | President and Fellows of Harvard College | Recapitulating the hematopoietic niche to reconstitute immunity |
| WO2017144548A1 (en) * | 2016-02-22 | 2017-08-31 | Onxeo | Combination therapies comprising immuno-oncology agents and doxorubicin-loaded poly(cyanoacrylate) nanoparticles |
| KR102413032B1 (ko) | 2016-03-01 | 2022-06-24 | 노쓰 캐롤라이나 스테이트 유니버시티 | 마이크로니들 패치-보조된 전달에 의한 향상된 암 면역요법 |
| WO2017210476A1 (en) | 2016-06-01 | 2017-12-07 | Duke University | Nonfouling biosensors |
| JP7185530B2 (ja) | 2016-06-13 | 2022-12-07 | トルク セラピューティクス， インコーポレイテッド | 免疫細胞機能を促進するための方法および組成物 |
| CN115404196A (zh) | 2016-07-13 | 2022-11-29 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
| CN110418651A (zh) | 2016-08-02 | 2019-11-05 | 哈佛学院院长等 | 用于调节免疫应答的生物材料 |
| EP3515928B1 (en) | 2016-09-23 | 2026-01-28 | Duke University | Unstructured non-repetitive polypeptides having lcst behavior |
| WO2018132732A1 (en) | 2017-01-12 | 2018-07-19 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
| US11260132B2 (en) | 2017-03-16 | 2022-03-01 | Children's Medical Center Corporation | Engineered liposomes as cancer-targeted therapeutics |
| CA3056802A1 (en) * | 2017-03-16 | 2018-09-20 | Children's Medical Center Corporation | Non-viral, non-cationic nanoparticles and uses thereof |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| WO2018213320A1 (en) | 2017-05-15 | 2018-11-22 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
| WO2019006374A1 (en) | 2017-06-30 | 2019-01-03 | Duke University | ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS |
| JP7285828B2 (ja) | 2017-09-05 | 2023-06-02 | トルク セラピューティクス， インコーポレイテッド | 治療用タンパク質組成物ならびにその作製および使用方法 |
| US12296018B2 (en) | 2018-01-26 | 2025-05-13 | Duke University | Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same |
| GB201804634D0 (en) * | 2018-03-22 | 2018-05-09 | Aqdot Ltd | Emulsion stabiliser |
| EP3788343B1 (en) | 2018-04-30 | 2024-03-27 | Duke University | Stimuli-responsive peg-like polymer-based drug delivery platform |
| WO2019217552A1 (en) * | 2018-05-09 | 2019-11-14 | Yale University | Particles for spatiotemporal release of agents |
| US20210275588A1 (en) * | 2018-07-10 | 2021-09-09 | The Regents Of The University Of California | Biomolecule Coated Particles and Films and Uses Thereof |
| WO2020014644A1 (en) * | 2018-07-12 | 2020-01-16 | The Regents Of The University Of Michigan | Compositions and methods for metal containing formulations capable of modulating immune response |
| EP3829622A4 (en) | 2018-08-02 | 2022-05-11 | Duke University | DOUBLE AGONIST FUSION PROTEINS |
| WO2020051541A1 (en) | 2018-09-07 | 2020-03-12 | Duke University | Nanoparticulate drug delivery systems |
| WO2020061129A1 (en) | 2018-09-19 | 2020-03-26 | President And Fellows Of Harvard College | Compositions and methods for labeling and modulation of cells in vitro and in vivo |
| EP3853258A4 (en) * | 2018-09-20 | 2022-11-16 | Arizona Board of Regents on behalf of the University of Arizona | TARGETED PART-DRUG-GRAFTED IMMUNE CELLS AND METHODS OF USE |
| EP4635486A3 (en) * | 2018-10-01 | 2025-12-24 | The Board of Trustees of the Leland Stanford Junior University | Injectable hydrogels for controlled release of immunomodulatory compounds |
| EP3866832B1 (en) * | 2018-10-19 | 2024-12-11 | University of Rochester | Immunomodulatory cytokines in combination with radiation treatment for unresectable pancreatic cancer |
| RU2706427C1 (ru) * | 2018-12-27 | 2019-11-19 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата |
| WO2020136657A1 (en) | 2018-12-28 | 2020-07-02 | Ramot At Tel-Aviv University Ltd. | Polymeric nanovaccines and uses thereof |
| WO2020150623A1 (en) * | 2019-01-18 | 2020-07-23 | University Of Georgia Research Foundation, Inc. | Salt nanoparticles and compositions and methods of use thereof |
| US12263252B2 (en) | 2019-06-05 | 2025-04-01 | The Florida International University Board Of Trustees | Biotherapy for viral infections using biopolymer based micro/nanogels |
| US20200383932A1 (en) * | 2019-06-05 | 2020-12-10 | The Florida International University Board Of Trustees | Biotherapy for viral infections using biopolymer based micro/nanogels |
| US20220249389A1 (en) * | 2019-07-12 | 2022-08-11 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
| WO2021011496A1 (en) * | 2019-07-12 | 2021-01-21 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| WO2021011501A1 (en) | 2019-07-12 | 2021-01-21 | Oregon Health & Science University | Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor |
| EP4031582A4 (en) * | 2019-09-18 | 2023-10-04 | The Regents of the University of California | IMMUNOACTIVE MICROPARTICLES AND ASSOCIATED USES |
| WO2021061837A1 (en) | 2019-09-23 | 2021-04-01 | President And Fellows Of Harvard College | Biomaterial-based antigen free vaccine and the use thereof |
| RU2712212C1 (ru) * | 2019-10-28 | 2020-01-27 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата |
| CA3160922A1 (en) | 2019-12-05 | 2021-06-10 | Brock A. LINDSEY | Protein-loaded plga nanospheres |
| WO2021137611A1 (ko) * | 2019-12-30 | 2021-07-08 | (주)테라베스트 | 나노 구조체가 부착된 면역세포 |
| US20230093708A1 (en) * | 2020-03-04 | 2023-03-23 | Duke University | Protein nanoparticle design and application |
| EP4149550A4 (en) * | 2020-05-15 | 2024-07-03 | The Board of Trustees of the Leland Stanford Junior University | TOLL-LIKE RECEPTOR (TLR) AGONIST NANOPARTICLES AND USES THEREOF |
| EP4175618A4 (en) * | 2020-07-01 | 2024-08-07 | Cello Therapeutics, Inc. | Platelet membrane coated nanoparticles and uses thereof |
| CN112451504B (zh) * | 2020-11-09 | 2022-10-18 | 四川大学华西医院 | 一种载EBV-LMP2 mRNA的核-壳纳米粒的制备方法及应用 |
| US11672875B2 (en) | 2021-03-17 | 2023-06-13 | Saint Louis University | Nanoparticle-alginate gels for X-ray imaging of the vasculature |
| WO2022225737A1 (en) * | 2021-04-20 | 2022-10-27 | Purdue Research Foundation | Immunofunctional carrier, methods of uses, and composition matters as an antitumor immunotherapy |
| GB2629999B (en) * | 2021-04-21 | 2025-03-26 | Act Therapeutics Ltd | Enhancement of treatment with immunotherapeutic agents |
| WO2022225203A1 (ko) * | 2021-04-23 | 2022-10-27 | 서울대학교산학협력단 | 대식세포의 활성 조절용 조성물 |
| WO2023113550A1 (ko) * | 2021-12-16 | 2023-06-22 | 주식회사 포투가바이오 | 수지상세포 모방 기능성 나노구조체 및 이의 제조방법 |
| WO2023113545A1 (ko) * | 2021-12-16 | 2023-06-22 | 주식회사 포투가바이오 | αPD-1를 포함하는 수지상 세포 모방 기능성 나노구조체 및 이의 제조방법 |
| NO20221187A1 (en) | 2022-11-04 | 2024-05-06 | Exact Therapeutics As | Method and system for calculating a point estimate of an ultrasound dose |
| WO2024128868A1 (ko) * | 2022-12-15 | 2024-06-20 | 주식회사 포투가바이오 | αPD-1를 포함하는 수지상 세포 모방 기능성 나노구조체 및 이의 제조방법 |
| CN116172980A (zh) * | 2022-12-28 | 2023-05-30 | 上海百心安生物技术股份有限公司 | 一种核壳结构胶束微球及其制备方法和应用 |
| CN118576717A (zh) * | 2023-03-01 | 2024-09-03 | 清华大学 | 生物分子递送载体及其制备和应用 |
| CN117731637A (zh) * | 2023-12-20 | 2024-03-22 | 上海爱莫思生物技术有限公司 | 一种mdp纳米颗粒及其应用 |
| WO2025149619A1 (en) * | 2024-01-12 | 2025-07-17 | Topas Therapeutics Gmbh | Nanoparticles comprising amphiphilic polymers and lipids for the targeted delivery of antigens |
| CN120324344B (zh) * | 2025-04-18 | 2025-10-17 | 广州医科大学附属第一医院横琴医院(横琴粤澳深度合作区中心医院) | 一种肿瘤微环境响应型级联靶向小激活核酸纳米药物的制备方法及其应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5138069A (en) | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| US5210079A (en) | 1988-01-07 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists |
| US5354867A (en) | 1988-12-06 | 1994-10-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| WO1995015746A1 (en) | 1993-12-10 | 1995-06-15 | The School Of Pharmacy | Liposome delivery systems |
| US7411051B2 (en) | 1997-03-07 | 2008-08-12 | Human Genome Sciences, Inc. | Antibodies to HDPPA04 polypeptide |
| IL149820A0 (en) | 2002-05-23 | 2002-11-10 | Curetech Ltd | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| ES2350687T3 (es) | 2002-07-03 | 2011-01-26 | Ono Pharmaceutical Co., Ltd. | Composiciones de inmunopotenciación. |
| US7052694B2 (en) | 2002-07-16 | 2006-05-30 | Mayo Foundation For Medical Education And Research | Dendritic cell potentiation |
| US7985422B2 (en) | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
| US7785578B2 (en) | 2002-10-11 | 2010-08-31 | Aciont, Inc. | Non-invasive ocular drug delivery |
| CN1753912B (zh) | 2002-12-23 | 2011-11-02 | 惠氏公司 | 抗pd-1抗体及其用途 |
| US20060099203A1 (en) | 2004-11-05 | 2006-05-11 | Pease Larry R | B7-DC binding antibody |
| JP2008512350A (ja) * | 2004-07-01 | 2008-04-24 | イェール ユニバーシティ | 標的化され、そして高密度で薬物が負荷されるポリマー性物質 |
| US20070166281A1 (en) | 2004-08-21 | 2007-07-19 | Kosak Kenneth M | Chloroquine coupled antibodies and other proteins with methods for their synthesis |
| RU2494107C2 (ru) | 2005-05-09 | 2013-09-27 | Оно Фармасьютикал Ко., Лтд. | Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами |
| EP3263581B2 (en) * | 2005-05-17 | 2025-07-09 | University of Connecticut | Compositions and methods for immunomodulation in an organism |
| CN101355965A (zh) | 2005-06-08 | 2009-01-28 | 达纳－法伯癌症研究院 | 通过抑制程序性细胞死亡1（pd-1）途经治疗持续性感染和癌症的方法及组合物 |
| US20070014845A1 (en) | 2005-07-01 | 2007-01-18 | Yuanpeng Zhang | Liposomal delivery vehicle for hydrophobic drugs |
| CN104356236B (zh) | 2005-07-01 | 2020-07-03 | E.R.施贵宝&圣斯有限责任公司 | 抗程序性死亡配体1(pd-l1)的人单克隆抗体 |
| DE102005039579B4 (de) | 2005-08-19 | 2022-06-30 | Magforce Ag | Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen |
| WO2007056539A2 (en) | 2005-11-08 | 2007-05-18 | Medarex, Inc. | Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy |
| US8658608B2 (en) | 2005-11-23 | 2014-02-25 | Yale University | Modified triple-helix forming oligonucleotides for targeted mutagenesis |
| US20080267455A1 (en) | 2005-12-20 | 2008-10-30 | Koninklijke Philips Electronics N. V. | Method for Movement Compensation of Image Data |
| JP2008053276A (ja) | 2006-08-22 | 2008-03-06 | Nec Electronics Corp | 半導体装置の製造方法 |
| CN103536915A (zh) | 2006-12-27 | 2014-01-29 | 埃默里大学 | 用于治疗传染病和肿瘤的组合物和方法 |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| BRPI0810899A2 (pt) * | 2007-04-13 | 2014-10-29 | Univ North Texas | Formulação de nanopartículas de plga ativadas carregadas com agente ativo para substâncias nano-terapêuticas anticâncer direcionais. |
| US20090028857A1 (en) | 2007-07-23 | 2009-01-29 | Cell Genesys, Inc. | Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| WO2009020094A1 (ja) | 2007-08-09 | 2009-02-12 | Daiichi Sankyo Company, Limited | 疎水性分子で修飾した抗体 |
| EA201000910A1 (ru) | 2007-11-30 | 2011-04-29 | Бристоль-Мейерз Сквибб Компани | Конъюгат "моноклональное антитело против в7н4/лекарственное средство" и способы его применения |
| CN102203132A (zh) | 2008-08-25 | 2011-09-28 | 安普利穆尼股份有限公司 | Pd-1拮抗剂的组合物和使用方法 |
| US8277812B2 (en) * | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
| US9283184B2 (en) * | 2008-11-24 | 2016-03-15 | Massachusetts Institute Of Technology | Methods and compositions for localized agent delivery |
| US20120021036A1 (en) | 2009-01-15 | 2012-01-26 | The Regents Of The University Of California | Composite nanostructures and methods for making and using them |
| CN102596178B (zh) | 2009-10-26 | 2014-12-03 | 石药集团中奇制药技术（石家庄）有限公司 | 具有磺丁基醚环糊精盐内水相的脂质体 |
| WO2011133803A1 (en) | 2010-04-21 | 2011-10-27 | Helix Therapeutics, Inc. | Compositions and methods for targeted inactivation of hiv cell surface receptors |
| US20110293690A1 (en) | 2010-05-27 | 2011-12-01 | Tyco Healthcare Group Lp | Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof |
| JP2013531043A (ja) | 2010-07-16 | 2013-08-01 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 癌の免疫療法のための方法及び組成物 |
| RU2013127625A (ru) * | 2010-11-18 | 2014-12-27 | Зе Дженерал Хоспитал Корпорейшен | Новые композиции и применения антигипертензивных средств для терапии рака |
| KR20140041522A (ko) * | 2011-05-09 | 2014-04-04 | 인스티튜트 퀴믹 데 사리아 | 약물 전달용 중합체 나노입자 |
| US9603800B2 (en) * | 2012-04-12 | 2017-03-28 | Yale University | Methods of treating inflammatory and autoimmune diseases and disorders using nanolipogels |
| KR102460800B1 (ko) | 2013-11-01 | 2022-10-31 | 예일 유니버시티 | 면역요법용 모듈러 입자 |
-
2014
- 2014-10-31 KR KR1020167014652A patent/KR102460800B1/ko active Active
- 2014-10-31 RU RU2016121422A patent/RU2672055C2/ru active
- 2014-10-31 EP EP14805404.2A patent/EP3062779B1/en active Active
- 2014-10-31 KR KR1020197032420A patent/KR20190126452A/ko not_active Ceased
- 2014-10-31 CA CA2929277A patent/CA2929277C/en active Active
- 2014-10-31 WO PCT/US2014/063545 patent/WO2015066535A1/en not_active Ceased
- 2014-10-31 AU AU2014342004A patent/AU2014342004B2/en active Active
- 2014-10-31 ES ES14805404T patent/ES2982087T3/es active Active
- 2014-10-31 JP JP2016527304A patent/JP6845691B2/ja active Active
- 2014-10-31 CN CN201480070407.XA patent/CN105848649B/zh active Active
- 2014-10-31 US US15/034,106 patent/US9884026B2/en active Active
- 2014-10-31 CA CA2987519A patent/CA2987519A1/en not_active Abandoned
- 2014-10-31 CN CN201910629569.7A patent/CN110302162A/zh active Pending
-
2016
- 2016-04-25 ZA ZA201602826A patent/ZA201602826B/en unknown
-
2017
- 2017-12-07 AU AU2017272274A patent/AU2017272274A1/en not_active Abandoned
-
2018
- 2018-01-03 US US15/860,888 patent/US10751291B2/en active Active
-
2019
- 2019-10-09 AU AU2019246802A patent/AU2019246802B2/en active Active
-
2020
- 2020-02-21 JP JP2020028424A patent/JP2020075940A/ja not_active Withdrawn
- 2020-02-21 JP JP2020028423A patent/JP6929572B2/ja active Active
- 2020-08-06 US US16/986,393 patent/US20210015758A1/en not_active Abandoned
-
2021
- 2021-08-26 AU AU2021221886A patent/AU2021221886A1/en not_active Abandoned
-
2022
- 2022-03-18 JP JP2022043714A patent/JP2022078345A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016536312A5 (https=) | ||
| Gong et al. | Enhancing in situ cancer vaccines using delivery technologies | |
| RU2016121422A (ru) | Модульные частицы для иммунотерапии | |
| Musetti et al. | Nanoparticle-mediated remodeling of the tumor microenvironment to enhance immunotherapy | |
| Bauleth‐Ramos et al. | Acetalated dextran nanoparticles loaded into an injectable alginate cryogel for combined chemotherapy and cancer vaccination | |
| Ramakrishnan et al. | Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer | |
| JP2019534308A5 (https=) | ||
| Xu et al. | Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12 | |
| Han et al. | Combination of Metal‐Phenolic Network‐Based Immunoactive Nanoparticles and Bipolar Irreversible Electroporation for Effective Cancer Immunotherapy | |
| JP2019532080A5 (https=) | ||
| WO2016004048A3 (en) | Targeted conjugates and particles and formulations thereof | |
| EP2620157A3 (en) | Vaccine nanotechnology | |
| Torres Andon et al. | Nanomedicine and cancer immunotherapy–targeting immunosuppressive cells | |
| Cao et al. | Reeducating tumor-associated macrophages using CpG@ Au nanocomposites to modulate immunosuppressive microenvironment for improved radio-immunotherapy | |
| García et al. | Self-assembled nanomaterials | |
| Seo et al. | Short review on advances in hydrogel-based drug delivery strategies for cancer immunotherapy | |
| JP2016513953A5 (https=) | ||
| EP3064220A3 (en) | Compositions and methods for the treatment of infections and tumors | |
| JP7570134B2 (ja) | 治療用ワクチンとしての使用のためのナノ粒子 | |
| CN106237340B (zh) | 透明质酸纳米颗粒在制备治疗淋巴系统肿瘤的药物的用途 | |
| Nikitczuk et al. | PLGA-polymer encapsulating tumor antigen and CpG DNA administered into the tumor microenvironment elicits a systemic antigen-specific IFN-γ response and enhances survival | |
| JP2012506394A5 (https=) | ||
| Khatua et al. | Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications | |
| Schafer et al. | NK cell exhaustion: bad news for chronic disease? | |
| Gorbet et al. | Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits |